Teladoc Health, Inc. (TDOC) Stock: Price, Forecast & Analyst Target
Teladoc Health, Inc. (TDOC) — MoonshotScore 17/100 (Weak band), calculated Oct 5, 2026. Price $5.52 (-2.65%), as of the Oct 2, 2026 trading session; market cap $1.00B.
Educational signal · not a buy or sell recommendation · How to read this
Teladoc Health, Inc. · TDOC · NYSE
Teladoc Health, Inc. is a global leader in virtual healthcare, providing a range of services and solutions for various medical conditions. The company operates in the United States and internationally, serving employers, health plans, and individual members through its telehealth platform.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · Teladoc Health (TDOC)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and durable growth, at a cheap price, but a fragile balance sheet. Business Quality: Elite; Financial Safety: Fragile; Valuation: Cheap; Growth Durability: Growing; Momentum: Slipping.
- quarterly revenue $607M (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 4 of 8
- Altman Z -7.37 · Piotroski F 5
Holding back: balance-sheet strain
Helping: business quality, an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 16 | Weak | |
| 17 | Weak | |
| 17 | Weak | |
| 17 | Weak | |
| 17 | Weak | |
| 17 | Weak |
The score was 17 in the stored Oct 4, 2026 snapshot and remains 17 in the current publication computed Oct 5, 2026 (0); the largest pillar moves were Growth Durability -1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $5.52 | |
| Change on the day | -2.65% | |
| 52-week range | $4.40 – $9.89 | |
| Market capitalisation | $1.00B | |
| Shares traded on the day | 4.89M |
Price & events
Other perspectives
Council score for Teladoc Health (TDOC): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 20, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the TDOC film — every key number, told as a short cinematic story
~2 min · open the film
What is Teladoc Health (TDOC), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Teladoc Health, Inc. (TDOC) is listed on NYSE. It employs 5,124 people and is led by Charles Divita. In Q2 FY2026 it reported revenue of $607M and net income of -$39M. The market values it at $1.00B.
What do the latest results show for Teladoc Health (TDOC)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $607M. Against analyst estimates the company has EPS beat 4 of 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $607M | -$39M | -$0.22 (diluted) |
| Q1 FY2026 | $614M | -$64M | -$0.36 (diluted) |
| Q4 FY2025 | $642M | -$25M | -$0.14 (diluted) |
| Q3 FY2025 | $626M | -$50M | -$0.28 (diluted) |
What are the financial strengths and risks for Teladoc Health (TDOC)?
Short answer
The MoonshotScore pillars rate business quality, an attractive price, durable growth as strengths. What is holding it back is balance-sheet strain. The distress and quality screens read Altman Z -7.37 · Piotroski F 5. Trailing ratios: ROE -13.1% · ROA -6.4% · current ratio 0.83 · earnings yield -17.4% · free-cash-flow yield 21.8%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -7.37 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-13.1%) — the business is not currently generating profit on shareholder capital.
What should you watch next at Teladoc Health (TDOC)?
Short answer · as of
Current published price targets run low $7.50 · high $11.00 · consensus $8.83 · median $8.00 against a quoted price of $5.52 (as of Oct 2, 2026).
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
How does Teladoc Health compare with its peers?
Short answer
Teladoc Health's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $216.50 Oct 2, 2026 | $1.49B | 98 5-pillar Oct 5, 2026 | |
| $25.23 Oct 2, 2026 | $1.98B | 91 5-pillar Oct 5, 2026 | |
| $30.82 Oct 2, 2026 | $900M | 90 5-pillar Oct 5, 2026 | |
| $33.60 Oct 2, 2026 | $1.53B | 80 5-pillar Oct 5, 2026 | |
| $20.35 Oct 2, 2026 | $459M | 73 5-pillar Oct 5, 2026 | |
| $10.07 Oct 2, 2026 | $622M | 68 5-pillar Oct 5, 2026 | |
| $3.28 Oct 2, 2026 | $1.14B | 46 5-pillar Oct 5, 2026 | |
| $20.37 Oct 2, 2026 | $1.21B | 43 5-pillar Oct 5, 2026 | |
| $9.36 Oct 2, 2026 | $1.46B | 37 5-pillar Oct 5, 2026 | |
| $20.30 Oct 2, 2026 | $2.56B | 35 5-pillar Oct 5, 2026 | |
| $73.09 Oct 2, 2026 | $2.18B | 32 5-pillar Oct 5, 2026 | |
| $30.31 Oct 2, 2026 | $2.26B | 31 5-pillar Oct 5, 2026 | |
| Teladoc Health (TDOC) — this page | $5.52 | $1.00B | 17 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $7.50 – $11.00
- Consensus target
- $8.83
- Median target
- $8.00
Consensus record · Captured .
Measured against a quoted price of $5.52 (as of Oct 2, 2026).
Insider activity
Form 4 records via FMP · Available records within the last 180 days, newest dated Sep 11, 2026 (coverage not recorded)
- Transactions
- 68
- Identified insiders
- 14
- Purchases
- 0
- Sales
- 14
- Other transactions
- 54
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
What has been published about Teladoc Health (TDOC)?
Investor Questions: TDOC Stock
These answers are editorial: 1 of these 9 answers is drawn from the TDOC research dossier (written May 7, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for TDOC?
TDOC carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is TDOC a good stock to buy?
Stock Expert AI does not rate TDOC buy, sell or hold. Teladoc Health, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the TDOC stock price today?
The last price recorded on this page for Teladoc Health, Inc. (TDOC) is $5.52, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the TDOC price target?
The analyst consensus price target for Teladoc Health, Inc. (TDOC) is $8.83 (range $7.50 to $11.00, median $8.00), per FMP data captured Oct 5, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
What does Teladoc Health, Inc. do?
Teladoc Health, Inc. operates as a virtual healthcare provider, offering a comprehensive suite of services that connect patients with doctors, therapists, and other healthcare professionals remotely.
What are the key factors to evaluate for TDOC?
Teladoc Health, Inc. (TDOC) holds a MoonshotScore in the low range. Analysts target $8.83 (+60%). The company serves a diverse range of clients, including employers, health plans, and individual members, providing a stable revenue base. Not financial advice.
How frequently does TDOC data refresh on this page?
TDOC's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven TDOC's recent stock price performance?
Teladoc Health, Inc. (TDOC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand recognition in the telehealth market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TDOC overvalued or undervalued right now?
Teladoc Health, Inc. (TDOC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $8.83 (+60%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 7, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (21 figures)
The 21 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 13 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $5.52 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T08:54:45.007Z. | |
px.change | Change on the day | -2.65% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $1.00B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-05T08:54:44.077Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | −$0.15 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $607M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.volume | Shares traded on the day | 4.89M | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_income | Net income, Q2 FY2026 | -$39M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
earn.pt | Stored analyst price targets | low $7.50 · high $11.00 · consensus $8.83 · median $8.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_range | Analyst price target, low to high | $7.50 – $11.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $8.83 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $8.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 68 transactions · 0 purchases, 14 sales, 54 other transactions · 14 identified insiders · available records within the last 180 days, newest dated Sep 11, 2026 (coverage not recorded) | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. |
UNRECORDED — 6 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 4 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-05 | |
fin.scores | Distress and quality screens | Altman Z -7.37 · Piotroski F 5 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
px.range52 | 52-week range | $4.40 – $9.89 | UNRECORDED | Stored company-profile observation — Captured 2026-10-05 | |
id.employees | Employees | 5,124 | UNRECORDED | Stored company-profile observation — Captured 2026-10-05 | |
id.ceo | Chief executive | Charles Divita | UNRECORDED | Stored company-profile observation — Captured 2026-10-05 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE -13.1% · ROA -6.4% · current ratio 0.83 · earnings yield -17.4% · free-cash-flow yield 21.8% | — | UNRECORDED | Stored key metrics — Date unknown |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 17 of 100 · Weak · pillars 83 / 9 / 87 / 70 / 35 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 17 (stored snapshot Oct 4, 2026) → 17 (current publication computed Oct 5, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.